Access to this symposium requires KEY ZONE access (paid
registration) to HDCN. For information about subscribing to HDCN,
please go to this link. |
The History and Challenges Involving Nephrology and the FDA
| Presentation and Speakers |
|
MP3 |
| Overview |
| Jonathan Himmelfarb, MD, FASN |
|
|
|
| From Discovery to Approval: History of ACE Inhibitors and Renal Endpoints |
| Edmund J. Lewis, MD |
|
|
|
| Proteinuria, Cyst Size, and GFR: Is There an "Ideal" Surrogate for Renal Disease? |
| Aliza M. Thompson, MD |
|
|
|
| What Should the Role be of the FDA? |
| Robert M. Califf, MD |
|
|
|
| Discussion |
| Drs Himmelfarbs, Lewis, Thompson,
and Califf |
|
|
|
|
Visit us next week for new topics !
|
|
